Home Aldehydes 1802706-04-2
1802706-04-2,MFCD30377223
Catalog No.:AA01EO9Y

1802706-04-2 | (S)-N-((5-(Ethylsulfonyl)pyridin-2-yl)methyl)-7-isopropyl-6-(((1r,4S)-4-(trifluoromethyl)cyclohexyl)methyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine-3-carboxamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
>98.00%
3 weeks  
$1,517.00   $1,062.00
- +
5mg
>98.00%
3 weeks  
$3,733.00   $2,613.00
- +
10mg
>98.00%
3 weeks  
$6,033.00   $4,223.00
- +
25mg
>98.00%
3 weeks  
$11,777.00   $8,244.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA01EO9Y
Chemical Name:
(S)-N-((5-(Ethylsulfonyl)pyridin-2-yl)methyl)-7-isopropyl-6-(((1r,4S)-4-(trifluoromethyl)cyclohexyl)methyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine-3-carboxamide
CAS Number:
1802706-04-2
Molecular Formula:
C27H35F3N4O3S
Molecular Weight:
552.6520
MDL Number:
MFCD30377223
SMILES:
CCS(=O)(=O)c1ccc(nc1)CNC(=O)c1cnc2c(c1)CN([C@H]2C(C)C)C[C@@H]1CC[C@H](CC1)C(F)(F)F
Properties

Literature

Title: Gege C. RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345. Expert Opin Ther Pat. 2017;27(1):1-8.

Title: Gerard McGeehan, et al. VTP-43742 is a potent and selective RORγt blocker that demonstrates oral efficacy in a mouse model of autoimmunity through suppression of IL-17A production (THER7P.945). J Immunol May 1, 2015, 194 (1 Supplement) 208.5-208.5.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1802706-04-2
Building Blocks
More >
Tags:1802706-04-2 Molecular Formula|1802706-04-2 MDL|1802706-04-2 SMILES|1802706-04-2 (S)-N-((5-(Ethylsulfonyl)pyridin-2-yl)methyl)-7-isopropyl-6-(((1r,4S)-4-(trifluoromethyl)cyclohexyl)methyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine-3-carboxamide